what is hers semaglutide compounded with hims review Hims & stock crashes after FDA announces plans to take "decisive steps" against GLP-1 compounds Hims cancels plans to sell

Recommended starting dose: Discontinue other basal insulin and/or GLP-1 agonist before initiating Soliqua Patients naive to basal insulin or a GLP-1 agonist, currently on a GLP-1 agonist or less than 30 units of basal insulin daily: starting dose is 15 units once daily Patients currently on 30 to 60 units of basal insulin daily, with or without a GLP-1 agonist: starting dose is 30 units once daily Maintenance: titrate dose up or down by 2 - 4 units every week based on blood sugar goals Missed doses: resume dosing at the next scheduled dose

Serlie, A

So it does seem that there is a ton of movement here, and and we and that the the I think from what Ive read, the price the price differences seem pretty significant

The company hasn't submitted its weight loss pill, orforglipron, to the agency yet